Cervix Uteri - Pathology
Research News and Information

Sunday, November 22, 2009

Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population--a candidate gene approach.

13 Oct 2009 High-risk human papillomavirus (hrHPV) infection is the major risk factor for cervical cancer (CxCa). The role of genetic susceptibility in the disease has been suggested, but the existing data lack consistency. We conducted a nested case-control ... Read more...

Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length.

29 Sep 2009 OBJECTIVE: The objective of the study was to assess cerclage to prevent recurrent preterm birth in women with short cervix. STUDY DESIGN: Women with prior spontaneous preterm birth less than 34 weeks were screened for short cervix and randomly ... Read more...

Viral load and physical status of human papillomavirus (HPV) 18 in cervical samples from female sex workers infected with HPV 18 in Burkina Faso.

29 Sep 2009 Viral DNA load and physical status might be predictive of either high-grade cervical lesions or disease progression among women infected by human papillomavirus (HPV) 16, but these virological markers have rarely been studied in HPV 18 infections. ... Read more...

Latest indexed articles for 'Cervix Uteri - Pathology'

These are the very latest articles for this heading:

• Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population--a candidate gene approach. 13 Oct 2009
• "String of pearls" appearance of blue blobs in postmenopausal atrophy on ThinPrep Pap test. 29 Sep 2009
• Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length. 29 Sep 2009
• Viral load and physical status of human papillomavirus (HPV) 18 in cervical samples from female sex workers infected with HPV 18 in Burkina Faso. 29 Sep 2009
• Cytologic detection of tuberculous cervicitis: a report of 7 cases. 30 Aug 2009
• Comprehensive amniotic fluid cytokine profile evaluation in women with a short cervix: which cytokine(s) correlates best with outcome? 30 Aug 2009
• Can we improve the detection of glandular cervical lesions: the role and limitations of the Pap smear diagnosis atypical glandular cells (AGC). 30 Aug 2009
• The effect of treatment with 17 alpha-hydroxyprogesterone caproate on changes in cervical length over time. 26 Aug 2009
• Outcome in women with no endocervical component on cervical cytology after treatment for high-grade cervical dysplasia. 30 Jul 2009
• [The role of colposcopy and typization of human papillomavirus in further diagnostic proceedings in patients with ASC-US cytological finding of the uterine cervix] 30 Jul 2009
• Comparison of fluorescence in situ hybridization, hybrid capture 2 and polymerase chain reaction for the detection of high-risk human papillomavirus in cervical cytology specimens. 30 Jul 2009
• Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women. 29 Jul 2009
• Endometrioid adenocarcinoma arising from endometriosis of the uterine cervix: a case report. 28 Jul 2009
• Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccine. 28 Jul 2009
• Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. 26 Jul 2009
• Age-specific prevalence of HPV genotypes in cervical cytology samples with equivocal or low-grade lesions. 19 Jul 2009
• Update on ASCCP consensus guidelines for abnormal cervical screening tests and cervical histology. 13 Jul 2009
• Human papillomavirus E7 oncoprotein overrides the tumor suppressor activity of p21Cip1 in cervical carcinogenesis. 5 Jul 2009
• [Carcinosarcomas (malignant mixed Mullerian tumors) of the uterus. Morphology, pathogenetic aspects and prognostic factors] 29 Jun 2009
• Utility of histiocytic immunomarkers in differentiating histiocytic aggregates with marked nuclear atypia from high grade squamous intraepithelial lesions in liquid-based cervicovaginal cytology specimens. 29 Jun 2009

See a longer list of these articles.

Technical information about 'Cervix Uteri'

Definition: The neck portion of the UTERUS between the lower isthmus and the VAGINA forming the cervical canal.

Descriptor UI: D002584

Alternative terms: Cervix Uteri; Cervixes; Uterine Cervix; Cervix, Uterine; Cervix;

Related Mesh Headings: Colposcopy;

Allowable Qualifiers: abnormalities; anatomy & histology; blood supply; cytology; drug effects; embryology; enzymology; growth & development; immunology; injuries; innervation; metabolism; microbiology; parasitology; pathology; physiology; physiopathology; radiation effects; radiography; radionuclide imaging; secretion; surgery; transplantation; ultrastructure; ultrasonography; chemistry; virology;

Tree Number: A05.360.319.679.256;

Online Note: use CERVIX UTERI to search CERVIX HYPERTROPHY 1966-96

History Note: CERVIX HYPERTROPHY was heading 1963-96

Technical Notes: inflammation = CERVICITIS; conization = CERVIX UTERI /pathol (IM) + CONIZATION (IM)